At Cadila Pharma, our purpose is to enable healthier lives by providing innovative and dependable neuro-psychiatric therapies that deliver superior patient outcomes.


Neurological and psychiatric conditions such as migraine, depression, and neuropathic pain affect millions of lives every day. These are not just medical conditions; they are experiences that disrupt daily routines, productivity, and impact emotional well-being. Migraines can strike without warning, depression can quietly cloud the mind, and neuropathic pain often lingers with constant suffering. For patients, the need is simple: relief that lasts.
Our therapeutic focus
The challenge lies in finding therapies that are trusted, evidence-based, and reliable enough. Our vision and efforts are focused on delivering long-term, patient-centric relief through our portfolio of neurology therapies.

We have built strength in the neuropathic pain segment:


In mental health, our antidepressant portfolio reflects a similar commitment:


For migraine management, we offer a portfolio of well-established therapies:

Brand names are for reference purpose only and shall not be treated as an advertisement. Please consult a registered medical practitioner before taking any medication.
Contact Us
Our Story
Businesses
Therapies
Corporate Identification No : U24231GJ1991PLC015132
©2026 Cadila Pharmaceuticals. All rights reserved